Anthony Gregg Lapointe - Jun 11, 2025 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Gregg Lapointe
Stock symbol
ATXS
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 07:12 PM
Previous filing
May 28, 2025
Next filing
Jun 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LAPOINTE ANTHONY GREGG Director C/O ASTRIA THERAPEUTICS, INC., 22 BOSTON WHARF ROAD, 10TH FLOOR, BOSTON /s/ Ben Harshbarger, as attorney-in-fact for Gregg Lapointe 2025-06-12 0001331860

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +26.6K $0.00 26.6K Jun 11, 2025 Common Stock 26.6K $5.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 11, 2025 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.